Tafasitamab
Generic Name: tafasitamab
Dosage form: POWDER. Active ingredients: TAFASITAMAB (200 mg/200mg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: TAFASITAMAB (200 mg/200mg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Dermatophagoides Farinae
dermatophagoides farinae
Standardized Insect Allergenic Extract [EPC]
11 DESCRIPTION Greer Standardized Mite ( Dermatophagoides farinae and/or Dermatophagoides pteronyssinus ) extracts are sterile solutions used for intradermal testing or subcutaneous immunotherapy. Each vial contains 5,000, 10,0000 or 30,000 Allergy Units/mL of sterile mite extract ( D. farinae and/or D. pteronyssinus ), 50% glycerin v/v, and 0.4% phenol (preservative). Inert ingredients include 0.50% sodium chloride for isotonicity and 0.25% sodium bicarbonate as a buffer.
Ll-37 (cap-18)
ll-37 (cap-18)
Dosage form: POWDER. Active ingredients: ROPOCAMPTIDE (1 g/g). Category: BULK INGREDIENT.
Bpc157 Acetate
bpc157 acetate
Dosage form: POWDER. Active ingredients: BPC-157 ACETATE (100 g/100g). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.